R&D News | pharmaphorum

News

Innoviva’s ‘game changer’ antibiotic tackles gonorrhoea

Innoviva has moved a step closer to bringing the first novel antibiotic to market for gonorrhoea in decades after reporting positive results in a phase 3 trial.

News

Kronos sheds staff despite positive data for cancer drug

A positive clinical trial is usually a signal for a biotech startup to press the accelerator on its spending, but Kronos Bio is taking a different tack.

News

Lexeo files $100m IPO in tough listing environment

Genetic medicine specialist Lexeo Therapeutics is the latest biotech to line up an initial public offering (IPO), aiming to raise around $100 million from the transaction.

News

Samay’s AI-enabled wearable ‘can diagnose COPD’

US start-up Samay has reported clinical data showing that its Sylvee wearable device can accurately diagnose chronic obstructive pulmonary disease (COPD), and even predict

News

Sangamo sheds staff once again in another retreat

Sangamo Therapeutics has announced another wave of job losses and a plan to license out two lead clinical programmes as it tries to reinvent itself as a neurology-focused

News

Cellectis rockets on gene-editing alliance with AstraZeneca

Shares in Cellectis shot up this morning after the French biotech revealed a wide-ranging alliance with AstraZeneca, which includes $245 million in near-term financial com

Innoviva’s ‘game changer’ antibiotic tackles gonorrhoea

Kronos sheds staff despite positive data for cancer drug

Lexeo files $100m IPO in tough listing environment

Samay’s AI-enabled wearable ‘can diagnose COPD’

Sangamo sheds staff once again in another retreat

Cellectis rockets on gene-editing alliance with AstraZeneca

Sandoz says it is entering "golden decade" in biosimilars

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks